Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MedX Health ( (TSE:MDX) ) has provided an announcement.
MedX Health Corp. has signed a commercial agreement with Health Partners Group, the UK’s largest occupational health services provider, to roll out its DermSecure® skin cancer screening platform following a successful pilot. This collaboration aims to provide rapid, non-invasive skin cancer assessments to thousands of at-risk employees, particularly outdoor and industrial workers, significantly reducing diagnosis times and enhancing preventive care in the workplace.
More about MedX Health
MedX Health Corp., based in Ontario, Canada, is a leader in non-invasive skin assessment and teledermatology. Their proprietary SIAscopy® technology, integrated into the DermSecure® platform, allows for pain-free, accurate imaging of skin lesions for rapid dermatologist review. The company’s products are approved for use in multiple countries, including Canada, the U.S., and the UK.
Average Trading Volume: 83,183
Technical Sentiment Signal: Sell
Current Market Cap: C$18.01M
For a thorough assessment of MDX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue